Literature DB >> 19806144

Epidemiology of pancreatic cancer: an overview.

Sara Raimondi1, Patrick Maisonneuve, Albert B Lowenfels.   

Abstract

Pancreatic cancer, although infrequent, has an exceptionally high mortality rate, making it one of the four or five most common causes of cancer mortality in developed countries. The incidence of pancreatic cancer varies greatly across regions, which suggests roles for lifestyle factors, such as diet, or environmental factors, such as vitamin D exposure. Smoking is the most common known risk factor, and is the cause of 20-25% of all pancreatic tumors. Alcohol does not seem to be a risk factor, unless it leads to chronic pancreatitis, which is a probable risk factor. Long-standing diabetes increases the risk of pancreatic cancer, but can also be an early manifestation of pancreatic tumors. 5-10% of patients with pancreatic cancer have an underlying germline disorder, while the remaining percentage of cancer cases is thought to be caused by somatic mutations. Some individual studies suggest that mutations in various polymorphic genes can lead to small increases in the risk of pancreatic cancer, but these findings need to be replicated. Rising prevalence of smoking in developing countries, improved diagnosis and increasing population longevity are all likely to increase the global burden of pancreatic cancer in the coming decades.

Entities:  

Mesh:

Year:  2009        PMID: 19806144     DOI: 10.1038/nrgastro.2009.177

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  120 in total

1.  Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.

Authors:  J Khasawneh; M D Schulz; A Walch; J Rozman; M Hrabe de Angelis; M Klingenspor; A Buck; M Schwaiger; D Saur; R M Schmid; G Klöppel; B Sipos; F R Greten; M C Arkan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

Review 2.  Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

3.  Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

Authors:  Alpa V Patel; Carmen Rodriguez; Leslie Bernstein; Ann Chao; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

4.  Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.

Authors:  Li Jiao; Melissa L Bondy; Manal M Hassan; David Z Chang; James L Abbruzzese; Douglas B Evans; Michael H Smolensky; Donghui Li
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

5.  XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; Robert A Wolff; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

6.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

7.  Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer.

Authors:  Sara H Olson; Irene Orlow; Jennifer Simon; Diana Tommasi; Pampa Roy; Sharon Bayuga; Emmy Ludwig; Ann G Zauber; Robert C Kurtz
Journal:  Cancer Detect Prev       Date:  2007-11-26

8.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

9.  Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study.

Authors:  Zhihong Gong; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer Causes Control       Date:  2009-05-05       Impact factor: 2.506

10.  A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.

Authors:  Björn Lindkvist; Dorthe Johansen; Anders Borgström; Jonas Manjer
Journal:  BMC Cancer       Date:  2008-11-05       Impact factor: 4.430

View more
  225 in total

1.  Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.

Authors:  Michael C Irizarry; David J Webb; Nada Boudiaf; John Logie; Laurel A Habel; Natalia Udaltsova; Gary D Friedman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-12-06       Impact factor: 2.890

2.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

3.  Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer.

Authors:  Seung-Mo Hong; Audrey Vincent; Mitsuro Kanda; Julie Leclerc; Noriyuki Omura; Michael Borges; Alison P Klein; Marcia Irene Canto; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

Review 4.  Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.

Authors:  Stephan Kruger; Michael Haas; Steffen Ormanns; Sibylle Bächmann; Jens T Siveke; Thomas Kirchner; Volker Heinemann; Stefan Boeck
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

5.  Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis.

Authors:  ChongLek Lee; Hang He; Yongjian Jiang; Yang Di; Feng Yang; Ji Li; Chen Jin; Deliang Fu
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

6.  IL-39 acts as a friend to pancreatic cancer.

Authors:  Alicia A Manning; Lei Zhao; Ziwen Zhu; Huaping Xiao; Chase G Redington; Vivi A Ding; Theodore Stewart-Hester; Qian Bai; Jacob Dunlap; Mark R Wakefield; Yujiang Fang
Journal:  Med Oncol       Date:  2018-12-01       Impact factor: 3.064

Review 7.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

8.  Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest.

Authors:  Melena D Bellin; Martin L Freeman; Andres Gelrud; Adam Slivka; Alfred Clavel; Abhinav Humar; Sarah J Schwarzenberg; Mark E Lowe; Michael R Rickels; David C Whitcomb; Jeffrey B Matthews; Stephen Amann; Dana K Andersen; Michelle A Anderson; John Baillie; Geoffrey Block; Randall Brand; Suresh Chari; Marie Cook; Gregory A Cote; Ty Dunn; Luca Frulloni; Julia B Greer; Michael A Hollingsworth; Kyung Mo Kim; Alexander Larson; Markus M Lerch; Tom Lin; Thiruvengadam Muniraj; R Paul Robertson; Seth Sclair; Shalinender Singh; Rachelle Stopczynski; Frederico G S Toledo; Charles Melbern Wilcox; John Windsor; Dhiraj Yadav
Journal:  Pancreatology       Date:  2013-11-13       Impact factor: 3.996

9.  Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1.

Authors:  Jian-Hong Zhang; Fu-Ji Lai; Hui Chen; Jiang Luo; Ri-Yuan Zhang; He-Qi Bu; Zhao-Hong Wang; Hong-Hai Lin; Sheng-Zhang Lin
Journal:  Oncol Lett       Date:  2012-10-24       Impact factor: 2.967

Review 10.  Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.

Authors:  Evelina Mocci; Roger L Milne; Elena Yuste Méndez-Villamil; John L Hopper; Esther M John; Irene L Andrulis; Wendy K Chung; Mary Daly; Saundra S Buys; Nuria Malats; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.